Immutep Limited (IMMP)
NASDAQ: IMMP · Real-Time Price · USD
1.740
+0.040 (2.35%)
Aug 13, 2025, 4:00 PM - Market closed
Immutep Market Cap
Immutep has a market cap or net worth of $240.21 million as of August 14, 2025. Its market cap has decreased by -6.90% in one year.
Market Cap
240.21M
Enterprise Value
137.06M
1-Year Change
-6.90%
Ranking
Category
Stock Price
$1.74
Market Cap Chart
Since April 19, 2012, Immutep's market cap has increased from $74.60M to $240.21M, an increase of 222.00%. That is a compound annual growth rate of 9.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 247.50M | -21.48% |
| Dec 31, 2024 | 315.20M | 10.60% |
| Dec 29, 2023 | 285.00M | 87.99% |
| Dec 30, 2022 | 151.60M | -38.22% |
| Dec 31, 2021 | 245.40M | 60.29% |
| Dec 31, 2020 | 153.10M | 152.22% |
| Dec 31, 2019 | 60.70M | 8.98% |
| Dec 31, 2018 | 55.70M | 70.34% |
| Dec 29, 2017 | 32.70M | 125.52% |
| Dec 30, 2016 | 14.50M | -27.50% |
| Dec 31, 2015 | 20.00M | 143.90% |
| Dec 31, 2014 | 8.20M | -29.91% |
| Dec 31, 2013 | 11.70M | -68.03% |
| Dec 31, 2012 | 36.60M | -50.94% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 589.61B |
| Johnson & Johnson | 418.98B |
| AbbVie | 355.57B |
| UnitedHealth Group | 244.92B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 224.52B |
| Novo Nordisk | 223.00B |